Alterations of gene expression of RB pathway in Opisthorchis viverrini infection-induced cholangiocarcinoma

Parasitology Research

Volumn 105, Issue 5, 2009, Pages 1273-1281

  Boonmars, Thidarut ^a,b   Wu, Zhiliang ^c   Boonjaruspinyo, Sirintip ^a,b   Pinlaor, Somchai ^a,b   Nagano, Isao ^c   Takahashi, Yuzo ^c   Kaewsamut, Butsara ^a   Yongvanit, Puangrat ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DIMETHYLNITROSAMINE; NUCLEAR PROTEIN; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HAMSTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KINETICS; MOLECULAR GENETICS; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPISTHORCHIASIS; OPISTHORCHIS VIVERRINI; PATHOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; CHOLANGIOCARCINOMA; CLONORCHIASIS; CRICETINAE; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; OPISTHORCHIS; RETINOBLASTOMA PROTEIN;

CRICETINAE; OPISTHORCHIS VIVERRINI;

EID: 70349586597     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-009-1548-0     Document Type: Article

References (51)

1. H Azechi N Nishida Y Fukuda T Nishimura M Minata H Katsuma M Kuno T Ito T Komeda R Kita R Takahashi K Nakao 2001 Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas Oncology 60 346 354 11408803 10.1159/000058531 1:CAS:528: DC%2BD3MXlsFShtb0%3D (Pubitemid 32623450)
2. T Boonmars T Srisawangwong P Srirach B Kaewsamut S Pinlaor P Sithithaworn 2007 Apoptosis-related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel Parasitol Res 102 57 62 17851691 10.1007/s00436-007-0724-3 1:STN:280:DC%2BD2snitl2ktg%3D%3D (Pubitemid 47622183)
3. T Boonmars P Srirach B Kaewsamut T Srisawangwong S Pinlaor P Pinlaor P Yongvanit P Sithithaworn 2008 Apoptosis-related gene expression in hamster opisthorchiasis post praziquantel treatment Parasitol Res 102 447 455 18058134 10.1007/s00436-007-0783-5 1:STN:280:DC%2BD1c%2FmtV2ltg%3D%3D
4. EE Bosco Y Wang H Xu JT Zilfou KE Knudsen BJ Aronow SW Lowe ES Knudsen 2007 The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer J Clin Invest 117 218 228 17160137 10.1172/JCI28803 1:CAS:528:DC%2BD2sXmvFSjsQ%3D%3D (Pubitemid 46048468)
5. F Cetani E Pardi P Viacava GD Pollina G Fanelli A Picone S Borsari E Gazzerro P Miccoli P Berti A Pinchera C Marcocci 2004 A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer Clin Endocrinol 60 99 106 10.1111/j.1365-2265.2004.01954.x 1:CAS:528:DC%2BD2cXhslGmtLc%3D (Pubitemid 38183505)
6. SJ Chatterjee R Datar D Youssefzadeh B George PJ Goebell JP Stein L Young SR Shi C Gee S Groshen DG Skinner RJ Cote 2004 Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma J Clin Oncol 22 1007 1103 14981105 10.1200/JCO.2004.05.174 1:CAS:528: DC%2BD2cXptlCkurk%3D (Pubitemid 41095032)
7. CS Chim KY Wong F Loong WW Lam G Srivastava 2007 Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma Hum Pathol 38 1849 1857 17900658 10.1016/j.humpath.2007.05.009 1:CAS:528:DC%2BD2sXhtlOls73J (Pubitemid 350179934)
8. SS Contu PC Contu DC Damin RB Fagundes F Bevilacqua AS Rosa JC Prolla LF Moreira 2007 pRB expression in esophageal mucosa of individuals at high risk for squamous cell carcinoma of the esophagus World J Gastroenterol 13 1728 1731 17461478 1:CAS:528:DC%2BD2sXlvFCmt7c%3D
9. KK Deeb AM Michalowska CY Yoon SM Krummey MJ Hoenerhoff C Kavanaugh MC Li FJ Demayo I Linnoila CX Deng EY Lee D Medina JH Shih JE Green 2007 Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis Cancer Res 67 8065 8080 17804718 10.1158/0008-5472.CAN-07-1515 1:CAS:528:DC%2BD2sXpvFKjtL0%3D (Pubitemid 47395141)
10. JA Diehl 2002 Cycling to cancer with cyclin D1 Cancer Biol Ther 1 226 231 12432268 1:CAS:528:DC%2BD3sXlt1Wisw%3D%3D
11. GG Fernandez-Ranvier E Khanafshar D Tacha M Wong E Kebebew QY Duh OH Clark 2009 Defining a molecular phenotype for benign and malignant parathyroid tumors Cancer 115 334 344 19107770 10.1002/cncr.24037
12. SH Friend R Bernards S Rogelj RA Weinberg JM Rapaport DM Albert TP Dryja 1986 A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma Nature 323 643 646 2877398 10.1038/323643a0 1:CAS:528:DyaL2sXhtl2qsw%3D%3D
13. G Garcea CP Neal CJ Pattenden WP Steward DP Berry 2005 Molecular prognostic markers in pancreatic cancer: a systematic review Eur J Cancer 41 2213 2236 16146690 10.1016/j.ejca.2005.04.044 1:CAS:528:DC%2BD2MXhtVynurfO (Pubitemid 41415597)
14. WC Hahn RA Weinberg 2002 Rules for making human tumor cells N Engl J Med 347 1593 1603 12432047 10.1056/NEJMra021902 1:CAS:528:DC%2BD38Xos1KhsLs%3D (Pubitemid 35315841)
15. JW Harbour SL Lai J Whang-Peng AF Gazdar JD Minna FJ Kaye 1988 Abnormalities in structure and expression of the human retinoblastoma gene in SCLC Science 241 353 357 2838909 10.1126/science.2838909 1:CAS:528: DyaL1cXlt1emsbo%3D
16. JW Harbour RX Luo A Dei Santi AA Postigo DC Dean 1999 Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1 Cell 98 859 869 10499802 10.1016/S0092- 8674(00)81519-6 1:CAS:528:DyaK1MXmt1GrsL8%3D (Pubitemid 29446902)
17. MR Haswell-Elkins P Sithithaworn D Elkins 1992 Opisthorchis viverrini and cholangiocarcinoma in northeast Thailand Parasitol Today 8 86 89 15463578 10.1016/0169-4758(92)90241-S 1:STN:280:DC%2BD2cvpvV2gsg%3D%3D
18. IARC Working Group 1994 Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis) IARC Monogr Eval Carcinog Risks Hum 61 121 175
19. K Ichikawa J Imura H Kawamata J Takeda T Fujimori 2002 Down-regulated p16 expression predicts poor prognosis in patients with extrahepatic biliary tract carcinomas Int J Oncol 20 453 461 11836554 1:STN:280:DC%2BD387gs1Sqsg%3D%3D
20. S Kakar LJ Burgart 2005 Tumors of the biliary system Curr Diagn Pathol 11 34 43 10.1016/j.cdip.2004.10.007 (Pubitemid 40221907)
21. YK Kang WH Kim JJ Jang 2002 Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma Hum Pathol 33 877 888 12378511 10.1053/hupa.2002.127444 1:CAS:528:DC%2BD38XotlGgsLw%3D
22. E Karamitopoulou L Tornillo I Zlobec L Cioccari V Carafa M Borner T Schaffner T Brunner I Diamantis A Zimmermann L Terracciano 2008 Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas Am J Clin Pathol 130 780 786 18854271 10.1309/AJCP35FDCAVANWMM 1:CAS:528: DC%2BD1cXhsVSjtrfP
23. FJ Kaye 2002 RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer Oncogene 21 6908 6914 12362273 10.1038/sj.onc.1205834 1:CAS:528:DC%2BD38XnsVKrurs%3D (Pubitemid 35221937)
24. SA Khan HC Thomas BR Davison SD Taylor-Robinson 2005 Cholangiocarcinoma Lancet 366 1303 1314 16214602 10.1016/S0140-6736(05)67530-7 (Pubitemid 41416587)
25. KE Knudsen JA Diehl CA Haiman ES Knudsen 2006 Cyclin D1: polymorphism, aberrant splicing and cancer risk Oncogene 25 1620 1628 16550162 10.1038/sj.onc.1209371 1:CAS:528:DC%2BD28XisFyhtbw%3D
26. Krinsky ML (2004) Cholangiocarcinoma. In: Johnson LR (ed) Encyclopedia of Gastroenterology. Academic Press, New York, pp 301-304
27. M Malumbres M Barbacid 2001 To cycle or not to cycle: a critical decision in cancer Nature Rev Cancer 1 222 231 10.1038/35106065 1:CAS:528: DC%2BD38XlvF2qtrg%3D
28. CN Mayhew SL Carter SR Fox CR Sexton CA Reed SV Srinivasan X Liu K Wikenheiser-Brokamp GP Boivin JS Lee BJ Aronow SS Thorgeirsson ES Knudsen 2007 RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis Gastroenterology 133 976 984 17854601 10.1053/j.gastro.2007.06.025 1:CAS:528:DC%2BD2sXhtFars77J (Pubitemid 47374137)
29. AP Mitra RH Datar RJ Cote 2006 Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification J Clin Oncol 24 5552 5564 17158541 10.1200/JCO.2006.08.2073 1:CAS:528: DC%2BD2sXmvVSqsA%3D%3D (Pubitemid 46631336)
30. C Pairojkul T Shirai S Hirohashi W Thamavit W Bhudhisawat T Uttaravicien M Itoh N Ito 1991 Multistage carcinogenesis of liver-fluke-associated cholangiocarcinoma in Thailand Princess Takamatsu Symp 22 77 86 1668894 1:STN:280:DyaK3s3gtlWgtg%3D%3D
31. I Palmero G Peters 1996 Perturbation of cell cycle regulators in human cancer Cancer Surv 27 351 367 8909810 1:CAS:528:DyaK28XntlSnsb4%3D
32. R Salgia TR Hedges M Rizk RH Reimer AT Skarin 1998 Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma Lung Cancer 22 149 152 10022222 10.1016/S0169-5002(98)00062-2 1:STN:280:DyaK1M7ksVyhsg%3D%3D (Pubitemid 29050856)
33. A Sgambato M Migaldi B Faraglia G De Aloysio P Ferrari R Ardito C De Gaetani G Capelli A Cittadini GP Trentini 2002 Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome Int J Cancer 97 671 678 11807796 10.1002/ijc.10055 1:CAS:528:DC%2BD38XpsFWitg%3D%3D (Pubitemid 34087809)
34. CJ Sherr JM Roberts 1999 CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev 13 1501 1512 10385618 10.1101/gad.13.12.1501 1:CAS:528:DyaK1MXktlOhsLs%3D
35. CJ Sherr F McCormick 2002 The RB and p53 pathways in cancer Cancer Cell 2 103 112 12204530 10.1016/S1535-6108(02)00102-2 1:CAS:528:DC%2BD38XmslSks7s%3D (Pubitemid 41039110)
36. P Sithithaworn M Haswell-Elkins 2003 Epidemiology of Opisthorchis viverrini Acta Trop 88 187 194 14611873 10.1016/j.actatropica.2003.02.001 (Pubitemid 37377814)
37. S Sriamporn P Pisani V Pipitgool K Suwanrungruang S Kamsa-ard DM Parkin 2004 Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, northeast Thailand Trop Med Int Health 9 588 594 15117303 10.1111/j.1365-3156.2004.01234.x 1:STN:280:DC%2BD2c3itVGmtg%3D%3D (Pubitemid 38657284)
38. B Sripa 2003 Pathobiology of opisthorchiasis: an update Acta Trop 88 209 220 14611875 10.1016/j.actatropica.2003.08.002 1:CAS:528:DC%2BD3sXovVWqs70%3D (Pubitemid 37377816)
39. B Sripa C Pairojkul 2008 Cholangiocarcinoma: lessons from Thailand Curr Opin Gastroenterol 24 349 356 18408464 10.1097/MOG.0b013e3282fbf9b3
40. K Sugimachi S Aishima K Taguchi S Tanaka M Shimada K Kajiyama K Sugimachi M Tsuneyoshi 2001 The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma J Hepatol 35 74 79 11495045 10.1016/S0168-8278(01)00079-4 1:CAS:528:DC%2BD3MXmtVylsL0%3D (Pubitemid 32646227)
41. A Tannapfel M Benicke A Katalinic D Uhlmann F Köckerling J Hauss C Wittekind 2000 Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver Gut 47 721 727 11034592 10.1136/gut.47.5.721 1:CAS:528:DC%2BD3cXosVSgurg%3D (Pubitemid 30809054)
42. A Tannapfel F Sommerer M Benicke L Weinans A Katalinic F Geissler D Uhlmann J Hauss C Wittekind 2002 Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma J Pathol 197 624 631 12210082 10.1002/path.1139 1:CAS:528:DC%2BD38Xntleku78%3D (Pubitemid 34906560)
43. W Thamavit R Kongkanuntn D Tiwawech MA Moore 1987 Level of Opisthorchis infestation and carcinogen dose-dependence of cholangiocarcinoma induction in Syrian golden hamsters Virchows Arch B Cell Pathol Incl Mol Pathol 54 52 58 2892303 10.1007/BF02899196 1:STN:280:DyaL1c7gtFentA%3D%3D
44. W Thamavit C Pairojkul D Tiwawech M Itoh T Shirai N Ito 1993 Promotion of cholangiocarcinogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation Carcinogenesis 14 2415 2417 8242874 10.1093/carcin/14.11.2415 1:CAS:528:DyaK2cXisFCjtA%3D%3D (Pubitemid 23335203)
45. SS Thorgeirsson JS Lee JW Grisham 2006 Molecular prognostication of liver cancer: end of the beginning J Hepatol l44 798 805 10.1016/j.jhep.2006.01.008
46. C Thuwajit P Thuwajit S Kaewkes B Sripa K Uchida M Miwa S Wongkham 2004 Increased cell proliferation of mouse fibroblast NIH-3T3 in vitro induced by excretory/secretory product(s) from Opisthorchis viverrini Parasitology 129 455 464 15521634 10.1017/S0031182004005815 1:CAS:528:DC%2BD2cXnsVyhuro%3D (Pubitemid 39371875)
47. C Thuwajit P Thuwajit K Uchida D Daorueang S Kaewkes S Wongkham M Miwa 2006 Gene expression profiling defined pathways correlated with fibroblast cell proliferation induced by Opisthorchis viverrini excretory/secretory product World J Gastroenterol 12 3585 3592 16773716 1:CAS:528:DC%2BD28XntVSrsLc%3D
48. Y Ustundag Y Bayraktar 2008 Cholangiocarcinoma: a compact review of the literature World J Gastroenterol 14 6458 6466 19030196 10.3748/wjg.14.6458
49. P Watanapa WB Watanapa 2002 Liver fluke-associated cholangiocarcinoma Br J Surg 89 962 970 12153620 10.1046/j.1365-2168.2002.02143.x 1:STN:280: DC%2BD38vgsVeitg%3D%3D (Pubitemid 34994687)
50. World Health Organization 1995 Control of foodborne trematode infections. Report of a WHO Study Group World Health Organ Tech Rep Ser 849 1 157
51. J Yuan J Knorr M Altmannsberger G Goeckenjan A Ahr A Scharl K Strebhardt 1999 Expression of p16 and lack of pRB in primary small cell lung cancer J Pathol 189 356 362 10.1002/(SICI)1096-9896(199911)189:3<358::AID- PATH452>3.0.CO;2-1 (Pubitemid 29489220)